Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics approaches to urologic diseases.

Brian C S Liu1, Joshua R Ehrlich

  • 1Molecular Urology Laboratory, Brigham & Women's Hospital, Harvard Medical School, 221 Longwood Avenue, LMRC-610, Boston, MA 02115, USA. bliu@partners.org

Expert Review of Proteomics
|June 15, 2006
PubMed
Summary

Biomarkers are crucial for diagnosing urologic diseases like interstitial cystitis and prostate cancer. This review discusses current biomarkers, discovery challenges, and strategies for clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual disability accommodations and ophthalmology.

BMJ open ophthalmology·2026
Same author

Vision loss, disability and multimorbidity among older people in Andhra Pradesh and Telangana in South India: the longitudinal eye health, ageing and disability study (LEADS) - study protocol.

BMJ public health·2026
Same author

A Clinically Relevant Threshold of Impaired Contrast Sensitivity Among Older US Adults.

JAMA ophthalmology·2026
Same author

Locally-affiliated authorship in global eye health research conducted in Sub-Saharan Africa between 2003 and 2022.

Eye (London, England)·2026
Same author

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same author

Well-child vision screening outcomes and guideline adherence at two major academic health systems in the United States.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2026

Area of Science:

  • Urology
  • Biomarker Discovery
  • Clinical Diagnostics

Background:

  • Significant need exists for reliable biomarkers in urologic diseases.
  • Current diagnostic tools lack specificity for conditions like interstitial cystitis, benign prostate hyperplasia, and urologic cancers.
  • Effective biomarkers are essential for timely diagnosis and treatment monitoring.

Purpose of the Study:

  • To review the current landscape of biomarkers for urologic diseases.
  • To identify limitations and challenges in biomarker discovery and validation.
  • To propose strategies for implementing biomarkers in clinical practice and drug discovery.

Main Methods:

  • Literature review of existing urologic biomarkers.
  • Analysis of challenges in biomarker research and development.

Related Experiment Videos

  • Discussion of implementation strategies for clinical application.

    • Main Results:

    • Identified key urologic diseases requiring novel biomarkers.
    • Outlined current limitations in biomarker availability and discovery.
    • Provided examples of biomarker strategies for clinical integration.

    Conclusions:

    • Biomarker development is critical for advancing urologic care.
    • Overcoming discovery hurdles is necessary for clinical translation.
    • Strategic implementation can improve patient outcomes in urologic oncology and other conditions.